ABT|Abbott Laboratories|株価:110.830|変動率:1.76

詳細情報 Abbott Laboratories 企業名

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.

Abbott Laboratoriesの企業情報



企業コードABT

会社名Abbott Laboratories

上場日Apr 06, 2073

最高経営責任者「CEO」Ford (Robert B)

従業員数114000

証券種類Ordinary Share

決算期末Apr 06

本社所在地100 Abbott Park Road

都市ABBOTT PARK

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国United States of America

郵便番号60064-3500

電話番号12246676100

ウェブサイトhttps://www.abbott.com

企業コードABT

上場日Apr 06, 2073

最高経営責任者「CEO」Ford (Robert B)

Abbott Laboratoriesの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Daniel J. Starks

Independent Director

6.74M

+10000.00%

Mr. Daniel Gesua Sive Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

132.23K

-1536.00%

Ms. Mary K. Moreland

Executive Vice President - Human Resources

95.58K

-791.00%

Ms. Lisa D. Earnhardt

Executive Vice President, Group President - Medical Devices

71.93K

--

Mr. Louis H. (Lou) Morrone

Executive Vice President - Core Diagnostics

66.61K

-269.00%

Mr. Philip P. Boudreau

Chief Financial Officer, Executive Vice President - Finance

50.97K

-387.00%

Dr. Robert J. Alpern, M.D.

Independent Director

40.80K

+1635.00%

Ms. Sally E. Blount, Ph.D.

Independent Director

34.06K

-965.00%

Mr. John G. Stratton

Independent Director

19.03K

+1635.00%

Ms. Michelle A. Kumbier

Independent Director

15.71K

+1635.00%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Daniel J. Starks

Independent Director

6.74M

+10000.00%

Mr. Daniel Gesua Sive Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

132.23K

-1536.00%

Ms. Mary K. Moreland

Executive Vice President - Human Resources

95.58K

-791.00%

Ms. Lisa D. Earnhardt

Executive Vice President, Group President - Medical Devices

71.93K

--

Mr. Louis H. (Lou) Morrone

Executive Vice President - Core Diagnostics

66.61K

-269.00%

Mr. Philip P. Boudreau

Chief Financial Officer, Executive Vice President - Finance

50.97K

-387.00%

収益内訳

通貨: USD更新時刻: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Diabetes Care

2.06B

18.09%

Core Laboratory

1.36B

12.00%

Structural Heart

1.28B

11.23%

Adult Nutritionals

1.18B

10.34%

Key Emerging Markets

1.10B

9.65%

他の

4.40B

38.68%

地域別USD

会社名

収益

比率

All other Countries

7.07B

62.19%

United States

4.30B

37.81%

事業別

地域別

事業別USD

会社名

収益

比率

Diabetes Care

2.06B

18.09%

Core Laboratory

1.36B

12.00%

Structural Heart

1.28B

11.23%

Adult Nutritionals

1.18B

10.34%

Key Emerging Markets

1.10B

9.65%

他の

4.40B

38.68%

株主

更新時刻: Mon, Nov 17

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

10.05%

BlackRock Institutional Trust Company, N.A.

5.13%

State Street Investment Management (US)

4.50%

Capital International Investors

3.54%

Capital Research Global Investors

2.23%

他の

74.55%

株主統計

比率

The Vanguard Group, Inc.

10.05%

BlackRock Institutional Trust Company, N.A.

5.13%

State Street Investment Management (US)

4.50%

Capital International Investors

3.54%

Capital Research Global Investors

2.23%

他の

74.55%

種類

株主統計

比率

Investment Advisor

47.28%

Investment Advisor/Hedge Fund

23.20%

Research Firm

3.50%

Pension Fund

2.39%

Bank and Trust

2.21%

Sovereign Wealth Fund

1.37%

Insurance Company

1.02%

Hedge Fund

0.49%

Individual Investor

0.48%

他の

18.07%

機関投資家保有株



更新時刻: Mon, Dec 8

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

4606

1.42B

81.82%

+3.92M

2025Q3

4681

1.42B

81.87%

+8.53M

2025Q2

4668

1.41B

81.51%

+6.23M

2025Q1

4636

1.40B

80.10%

+7.18M

2024Q4

4554

1.38B

78.81%

+33.68M

2024Q3

4367

1.35B

78.83%

-5.95M

2024Q2

4376

1.35B

78.36%

+5.03M

2024Q1

4375

1.35B

77.56%

-1.86M

2023Q4

4400

1.34B

77.62%

+7.10M

2023Q3

4258

1.33B

78.26%

-4.16M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

174.89M

10.06%

+2.54M

+1.47%

Nov 28, 2025

BlackRock Institutional Trust Company, N.A.

89.23M

5.13%

+711.43K

+0.80%

Sep 30, 2025

State Street Investment Management (US)

78.23M

4.5%

-128.28K

-0.16%

Sep 30, 2025

Capital International Investors

61.61M

3.54%

+1.48M

+2.46%

Sep 30, 2025

Capital Research Global Investors

38.77M

2.23%

-3.00M

-7.18%

Sep 30, 2025

Geode Capital Management, L.L.C.

38.54M

2.22%

+248.83K

+0.65%

Sep 30, 2025

Wellington Management Company, LLP

23.25M

1.34%

-1.80M

-7.20%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

22.25M

1.28%

+1.27M

+6.03%

Jun 30, 2025

JP Morgan Asset Management

19.25M

1.11%

-7.14M

-27.05%

Sep 30, 2025

T. Rowe Price Investment Management, Inc.

17.77M

1.02%

+9.40M

+112.38%

Sep 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 13.90B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Dec 12, 2025

ABT.NB Final Cash Dividend of gross USD 0.63 paid on Feb 13, 2026 going ex on Jan 15, 2026 with reinvestment option

Jan 15, 2026

Feb 13, 2026

Jan 15, 2026

Sep 19, 2025

ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Nov 17, 2025 going ex on Oct 15, 2025 with reinvestment option

Oct 15, 2025

Nov 17, 2025

Oct 15, 2025

Jun 13, 2025

ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Aug 15, 2025 going ex on Jul 15, 2025 with reinvestment option

Jul 15, 2025

Aug 15, 2025

Jul 15, 2025

Feb 21, 2025

ABT.NB Interim Cash Dividend of gross USD 0.59 paid on May 15, 2025 going ex on Apr 15, 2025 with reinvestment option

Apr 15, 2025

May 15, 2025

Apr 15, 2025

Dec 13, 2024

ABT.NB Final Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option

Jan 15, 2025

Feb 14, 2025

Jan 15, 2025

Sep 19, 2024

ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024

Oct 15, 2024

Nov 15, 2024

Oct 15, 2024

Jun 15, 2024

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option

Jul 15, 2024

Aug 15, 2024

Jul 15, 2024

Feb 16, 2024

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024

Apr 15, 2024

May 15, 2024

Apr 12, 2024

Dec 15, 2023

ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option

Jan 12, 2024

Feb 15, 2024

Jan 11, 2024

Sep 21, 2023

ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option

Oct 13, 2023

Nov 15, 2023

Oct 12, 2023

詳細を見る

株式分割



日付

配当落ち日

種類

比率

データなし

日付

配当落ち日

種類

比率

データなし

Abbott Laboratories

詳細情報 Abbott Laboratories 企業名

Abbott Laboratoriesの企業情報

Abbott Laboratoriesの経営陣

収益内訳

株主

機関投資家保有株

株主動向

関連ETF

配当金

株式分割